3uuo: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "3uuo" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 3: | Line 3: | ||
The entry 3uuo is ON HOLD | The entry 3uuo is ON HOLD | ||
Authors: Ho, G. D., Yang, S., Smotryski, J., Bercovici, A., Nechuta, T., Smith, E. M., McElroy, W., Tan, Z., Tulshian, D., Mckittrick, B., Greenlee, W. J., Hruza, A., Xiao, L., Rindgen, D., Guzzi, M., Zhang, X., Bleickardt, C., Mullins, D., Hodgson, R. | Authors: Ho, G.D., Yang, S., Smotryski, J., Bercovici, A., Nechuta, T., Smith, E.M., McElroy, W., Tan, Z., Tulshian, D., Mckittrick, B., Greenlee, W.J., Hruza, A., Xiao, L., Rindgen, D., Guzzi, M., Zhang, X., Bleickardt, C., Mullins, D., Hodgson, R. | ||
Description: The discovery of potent, selectivity, and orally bioavailable pyrozoloquinolines as PDE10 inhibitors for the treatment of Schizophrenia | Description: The discovery of potent, selectivity, and orally bioavailable pyrozoloquinolines as PDE10 inhibitors for the treatment of Schizophrenia | ||
